Skip to main content

GE Healthcare, Decision Biomarkers


GE Healthcare this week launched its illustra GenomiPhi HY DNA Amplification Kit and the illustra GenomiPhi V2 DNA Amplification Kit, both of which it recommends for genomic DNA preparation.

According to GE, the illustra GenomiPhi kits provide a method for genomic DNA stock replenishment and for DNA preparation upstream of PCR, genotyping, array comparative genomic hybridization, and cloning applications. Both kits use GE Healthcare's Phi 29 DNA polymerase technology which is based on an isothermal method of whole genome amplification, the company said.

GE also said that the GenomiPhi HY kit is a new offering for midi-scale DNA preparation, while the GenomiPhi V2 kit replaces GE Healthcare's original GenomiPhi kit for small-scale DNA preparation.

Decision Biomarkers last week launched its 8-Plex Cytokine Max Biochip that the company claims enables drug researchers to test for eight standard biomarkers linked to several inflammatory disorders at the same time.

The company also announced the availability of its iMark Biochip for use in customizable assays.

Both biochips are used in the Avantra Q400 Biomarker Workstation, DBI's flagship multiplexed-immunoassay system, which was formerly called the MultiMark Express.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.